I. Roca 1 , M. Akova 2 , 25 , F. Baquero 3 , J. Carlet 4 , M. Cavaleri 5 , S. Coenen 6 , J. Cohen 7 , D. Findlay 8 , I. Gyssens 9 , O.E. Heure 10 , G. Kahlmeter 11 , 25 , 26 , H. Kruse 12 , R. Laxminarayan 13 , 14 , E. Liébana 15 , L. López-Cerero 16 , A. MacGowan 17 , 26 , M. Martins 18 , J. Rodríguez-Baño 19 , 25 , J.-M. Rolain 20 , C. Segovia 21 , B. Sigauque 22 , E. Taconelli 23 , 25 , E. Wellington 24 , J. Vila 1 , 25 , ∗
16 April 2015
Antibiotic consumption, antibiotic resistance, antibiotic stewardship, antibiotics as growth promoters, drug discovery, infection control measures, multidrug resistant bacteria, self-medication, surveillance, wastewater treatment plants
In the last decade we have witnessed a dramatic increase in the proportion and absolute number of bacterial pathogens resistant to multiple antibacterial agents. Multidrug-resistant bacteria are currently considered as an emergent global disease and a major public health problem. The B-Debate meeting brought together renowned experts representing the main stakeholders (i.e. policy makers, public health authorities, regulatory agencies, pharmaceutical companies and the scientific community at large) to review the global threat of antibiotic resistance and come up with a coordinated set of strategies to fight antimicrobial resistance in a multifaceted approach. We summarize the views of the B-Debate participants regarding the current situation of antimicrobial resistance in animals and the food chain, within the community and the healthcare setting as well as the role of the environment and the development of novel diagnostic and therapeutic strategies, providing expert recommendations to tackle the global threat of antimicrobial resistance.